McKeith I G, Fairbairn A F, Bothwell R A, Moore P B, Ferrier I N, Thompson P, Perry R H
MRC Neurochemical Pathology Unit, Brighton Clinic, Newcastle Mental Health (NHS) Trust, Newcastle General Hospital, Newcastle upon Tyne, UK.
Neurology. 1994 May;44(5):872-7. doi: 10.1212/wnl.44.5.872.
Several recent autopsy studies suggest that senile dementia of Lewy body type (SDLT) may be the second most common neuropathologic cause of dementia in the elderly, accounting for 7 to 30% of all cases. Operational criteria for the antemortem clinical diagnosis of SDLT have already been proposed by our group. The performance of these is now examined by randomizing the case notes from a new series of SDLT, Alzheimer, and multi-infarct dementia patients for psychiatric assessment by four raters of varying clinical experience and blind to pathologic diagnosis. Using the SDLT criteria, the two most experienced raters agreed in 94% of cases (kappa = 0.87), with the least experienced rater agreeing in 78% (kappa = 0.50). Diagnostic specificity for SDLT was uniformly high (90.0 to 97.0%), with a mean sensitivity of detection of 74%, and was greater by the experienced (90.0%) than the least experienced (55%) clinician. The antemortem identification of SDLT patients can therefore be achieved with a high degree of diagnostic specificity using such operationalized criteria, although there remains a minority of patients who present with either "typical" Alzheimer-type symptoms or with paranoid or delusional symptoms in the absence of substantial cognitive impairment. Sensitivity to neuroleptics may be a useful diagnostic pointer in these patients.
最近的几项尸检研究表明,路易体痴呆症(SDLT)可能是老年人痴呆症第二常见的神经病理学病因,占所有病例的7%至30%。我们小组已经提出了SDLT生前临床诊断的操作标准。现在通过将一系列新的SDLT、阿尔茨海默病和多发梗死性痴呆患者的病例记录随机分配给四名临床经验不同且对病理诊断不知情的评估者进行精神评估,来检验这些标准的性能。使用SDLT标准,两名经验最丰富的评估者在94%的病例中意见一致(kappa = 0.87),经验最少的评估者在78%的病例中意见一致(kappa = 0.50)。SDLT的诊断特异性始终很高(90.0%至97.0%),平均检测灵敏度为74%,经验丰富的临床医生(90.0%)比经验最少的临床医生(55%)更高。因此,使用这样的操作标准可以高度特异性地在生前识别SDLT患者,尽管仍有少数患者表现出“典型”的阿尔茨海默病型症状或在没有明显认知障碍的情况下出现偏执或妄想症状。对这些患者来说,对神经阻滞剂的敏感性可能是一个有用的诊断指标。